GC Pharma partners with Atomwise for hemophilia
GC Pharma taps Atomwise to expand its hemophilia franchise
Hematology
Polygenic scores can predict predisposition to blood diseases
Studies identify bulk of genetic variations that influence blood cell traits
A device for detecting blood clots
Biomedical engineering researchers design a medical device that mimics blood vessels
A potential COVID-19 treatment gears up for trials
Revive Therapeutics files a Pre-CTA meeting request with Health Canada for Bucillamine in the treatment of COVID-19
Targeted drugs and immunotherapies may lower risk of hematologic cancers
Trend of reduced therapy-related hematologic cancers among patients with three cancer types likely driven by immune modulation, Roswell Park team proposes
Aiming to better tackle relapse
Purdue startup gets $2 million SBIR grant to fast-track cancer drug platform technology
Negative Data Prize is a positive?
Global Preclinical Data Forum says sharing negative science results is key to neuroscience progress
Well-tolerated tumor drug
Antibody therapeutic from Compugen demonstrates no dose-limiting toxicities
Early culprits
Multi-institution research team finds that cancer-driving mutations can arise in endometrial cells early in life
PTC Therapeutics snags sepiapterin in acquisition
PTC Therapeutics enters into an agreement to acquire Censa Pharmaceuticals
